Navigation Links
San Diego Medical Director Wins Two Book Awards For Latest Medical Thriller
Date:6/25/2012

San Diego, CA (PRWEB) June 25, 2012

Flashblind, a controversial medical thriller, released in April of 2012, has just been named as one of the winners in the New York Book Festival and the Beach Book Festival.

Award-winning author and medical director for the largest medical group in San Diego, Dr. Paul Bernstein will discuss this new and highly acclaimed medical thriller, Flasblind at a book signing on Sunday, August 5 from 12 p.m. to 2 p.m.at Warwicks at 7812 Girard Avenue, La Jolla.

Dr. Bernstein’s Flashblind brings to light the controversial theory behind government sponsored human radiation experiments or using humans as guinea pigs. The thriller begins as the race for the genetic holy grail, the cure for cancer, is on. World renowned geneticist, Jake Holden, has less than a month to complete his research that will save his brother. Jake is mired in a government conspiracy and pitted against a multibillion dollar pharmaceutical conglomerate.

Big Pharma wants to patent the cure. A trillion dollar drug. Jake wants the cure for his brother and the public good.

The US Department of Energy, the same agency responsible for testing nuclear bombs, has funded genetic research and human experiments since the dawn of the atomic age. The possible cure for cancer, also the key to an antidote for radiation poisoning, is kept secret.

Not only is Jake’s research and his brother’s life at stake, his own life is threatened.

How far would our government go to win a nuclear war? Would they allow thousands to die each year from cancer as part of a conspiracy of secrecy?

The greatest scientific race of modern time has the potential to either cure or kill. End the suffering of millions now or enable American to survive a nuclear war.

For more information please contact the author at paulbernstein(at)flashblindnovel(dot)com or for rights information publisher ZOVA Books at zovabooks(at)gmail(dot)com.

About the author:
Paul Bernstein, MD, author of the acclaimed novel, Courage to Heal, is a Head and Neck Surgeon and the Medical Director for the largest medical group in San Diego. In addition to being the former Chair of the Head and Neck division of the American Cancer Society, he has appeared on CBS, CNN, Fox, NBC and local media outlets as a medical expert.

About the publisher:

ZOVA Books is a publishing firm located in Los Angeles, California that publishes genre fiction titles, including works by New York Times #1 bestselling authors Michael Blake (“Dances With Wolves,” “The Holy Road,” “Into The Stars”) and Anna Lee Waldo (“Sacajawea,” “Watch the Face of the Sky”), as well as debut YA author Jessica Therrien (“Oppression”), and Kirkus Star recipient Clive London (“Prince Albert and the Doomsday Device”). ZOVA Books’ film, television and foreign rights are managed by Hollywood production and management company Circle of Confusion and Whitney Lee of The Fielding Agency.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9635343.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Related biology technology :

1. aTyr Pharma Receives Industry Innovation Awards from TiE and San Diego Venture Group
2. NIRI San Diego May Meeting: Seasoned IROs Discuss "Tips & Tactics for Establishing and Maintaining A Successful Investor Relations Program"
3. Entrepreneurs to Eat Problems for Breakfast in San Diego
4. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
5. The Spring 2012 MediSend Biomedical Repair Training Program™ Sends Graduating Biomedical Technicians to Hospitals Around the World
6. West Wireless Health Institute Applauds House Passage of Bill to Streamline FDA Medical Device Approval Process, Expedite Mobile Medical App Guidance
7. Dr. Victor Ambros and Dr. Gary Ruvkun Win 2012 Dr. Paul Janssen Award for Biomedical Research for Discovery of MicroRNAs
8. Medicalbillersandcoders.com Puts Forward Medical Billing Services to Physicians Facing Mid year Crisis
9. KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
10. Medical Marijuana Inc. Advisory Committee and Board of Directors Update
11. QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
San Diego Medical Director Wins Two Book Awards For Latest Medical Thriller
(Date:3/23/2017)... GREENWOOD VILLAGE, Colo. , March 23, 2017 /PRNewswire/ ... million in Series A financing and note conversion to ... products. Cool Planet is focused on developing products that ... raised nearly $30 million in the last 18 months. ... Coppel and North Bridge Venture Partners. ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
(Date:3/22/2017)... , March 22, 2017 ... fragmented, states a research report by Transparency Market Research ... Inc., Amgen Inc., and AbbVie Inc., accounted for a ... The prominent players in this market are focusing aggressively ... product portfolio, which is likely to lead to market ...
(Date:3/22/2017)... (PRWEB) , ... March 21, 2017 , ... Premier executive ... & Life Science Search Firm by Hunt Scanlon Media. , Hunt Scanlon ... and the most widely referenced global news source in the human capital sector. , ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Summary ... to better understand Merck KGaA and its partnering interests ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and ... the partnering activity of one of the world,s leading ... are prepared upon purchase to ensure inclusion of the ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
Breaking Biology News(10 mins):